Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
Author:
Affiliation:
1. Alberta Diabetes Institute, Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
Funder
Canadian Institutes of Health Research
Dr Rod Eidem Diabetes Research Fund
Dr Charles A. Allard Chair in Diabetes Research
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine
Link
http://academic.oup.com/eurheartj/article-pdf/42/36/3739/40428835/ehab563.pdf
Reference16 articles.
1. An update on sodium–glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus;Hsia;Curr Opin Endocrinol Diabetes Obes,2016
2. Empagliflozin reduced mortality and hospitalization for heart failure across the spectrum of cardiovascular risk in the EMPA-REG OUTCOME trial;Fitchett;Circulation,2019
3. The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium–Glucose Cotransporter-2 Inhibitors). Lower risk of heart failure and death in patients initiated on sodium–glucose cotransporter-2 inhibitors versus other glucose-lowering drugs;Kosiborod;Circulation,2017
4. Canagliflozin and heart failure in type 2 diabetes mellitus;Rådholm;Circulation,2018
5. Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus;Kato;Circulation,2019
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin Inhibits Long QT 3 Late Sodium Currents in a Mutation Specific Manner;2024-04-22
2. The therapeutic potential of ketones in cardiometabolic disease: impact on heart and skeletal muscle;American Journal of Physiology-Cell Physiology;2024-02-01
3. Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study;Diabetes Care;2023-12-05
4. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes;European Heart Journal;2023-08-25
5. Effect of sodium glucose cotransporter 2 inhibitors on atrial tachy‐arrhythmia burden in patients with cardiac implantable electronic devices;Journal of Cardiovascular Electrophysiology;2023-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3